How are Glyburide adverse event reports trending over time?
This graph shows volume of adverse events submitted to the FDA by quarter for Glyburide, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Glyburide is flagged as the suspect drug causing the adverse event.
What are the most common Glyburide adverse events reported to the FDA?
Hypoglycaemia | 537 (8.88%) |
Blood Glucose Increased | 160 (2.65%) |
Blood Glucose Decreased | 107 (1.77%) |
Renal Failure Acute | 96 (1.59%) |
Drug Interaction | 85 (1.41%) |
Completed Suicide | 78 (1.29%) |
Diarrhoea | 68 (1.12%) |
Drug Ineffective | 64 (1.06%) |
Lactic Acidosis | 63 (1.04%) |
Confusional State | 60 (.99%) |
Nausea | 58 (.96%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top adverse events submitted to the FDA for Glyburide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Glyburide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
What are the most common Glyburide adverse events reported to the FDA?
Glucose Metabolism Disorders | 655 (10.83%) |
Neurological | 419 (6.93%) |
Metabolic, Nutritional And Blood Ga... | 351 (5.8%) |
Medication Errors | 216 (3.57%) |
Therapeutic And Nontherapeutic Effe... | 204 (3.37%) |
Gastrointestinal Signs | 184 (3.04%) |
Renal Disorders | 165 (2.73%) |
Respiratory | 138 (2.28%) |
Epidermal And Dermal Conditions | 133 (2.2%) |
Acid-base | 126 (2.08%) |
Infections - Pathogen Unspecified | 121 (2%) |
Show More |
Share/Embed Graph Export Data
This graph shows the top categories of adverse events submitted to the FDA for Glyburide, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Glyburide is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.
Why are people taking Glyburide, according to those reporting adverse events to the FDA?
Diabetes Mellitus | 2604 |
Type 2 Diabetes Mellitus | 858 |
Product Used For Unknown Indication | 507 |
Drug Use For Unknown Indication | 498 |
Diabetes Mellitus Non-insulin-depen... | 218 |
Hyperglycaemia | 46 |
Show More |
Label | Labeler | Effective |
---|---|---|
Glyburide | DAVA Pharmaceuticals, Inc. | 21-JAN-09 |
Glyburide And Metformin Hydrochloride | Dr. Reddy's Laboratories Limited | 23-JUN-09 |
Glyburide (micronized) And Metformin Hydrochloride | Actavis Pharma Manufacturing Pvt. Ltd. | 24-MAR-10 |
Glyburide And Metformin Hydrochloride | Actavis Elizabeth LLC | 30-MAR-10 |
Glyburide And Metformin Hydrochloride | Preferred Pharmaceuticals, Inc | 30-MAR-10 |
Glyburide | Contract Pharmacy Services-PA | 12-APR-10 |
Micronase | Pharmacia and Upjohn Company | 10-MAY-10 |
Glyburide | Physicians Total Care, Inc. | 18-MAY-10 |
Glyburide (micronized) And Metformin Hydrochloride | Actavis Inc. | 08-SEP-10 |
Glyburide | UDL Laboratories, Inc. | 17-SEP-10 |
Glyburide | McKesson Packaging Services Business Unit of McKesson Corporation | 23-SEP-10 |
Glyburide | Rebel Distributors Corp | 28-SEP-10 |
Glyburide | Major Pharmaceuticals | 07-OCT-10 |
Glyburide | REMEDYREPACK INC. | 11-OCT-10 |
Glyburide And Metformin | Rebel Distributors Corp | 28-DEC-10 |
Glyburide And Metformin | PD-Rx Pharmaceuticals, Inc. | 02-JAN-11 |
Glyburide And Metformin | Unit Dose Services | 02-JAN-11 |
Glynase | Pharmacia and Upjohn Company | 28-FEB-11 |
Glyburide | Legacy Pharmaceutical Packaging | 08-APR-11 |
Glyburide | REMEDYREPACK INC. | 18-APR-11 |
Glyburide | West-ward Pharmaceutical Corp | 27-APR-11 |
Glyburide | Mylan Pharmaceuticals Inc. | 18-MAY-11 |
Glyburide | PD-Rx Pharmaceuticals, Inc. | 18-MAY-11 |
Glyburide | PD-Rx Pharmaceuticals, Inc. | 18-MAY-11 |
Glyburide And Metformin Hydrochloride | Aurobindo Pharma Limited | 29-JUN-11 |
Glyburide | REMEDYREPACK INC. | 08-JUL-11 |
Glyburide | Unit Dose Services | 18-JUL-11 |
Glyburide | MedVantx, Inc. | 18-JUL-11 |
Glyburide | PD-Rx Pharmaceuticals, Inc. | 02-AUG-11 |
Glyburide | REMEDYREPACK INC. | 23-AUG-11 |
Glyburide | Lake Erie Medical DBA Quality Care Products LLC | 13-DEC-11 |
Glyburide And Metformin | Physicians Total Care, Inc. | 20-DEC-11 |
Glyburide And Metformin | Rebel Distributors Corp | 20-DEC-11 |
Glyburide | Rebel Distributors Corp | 27-DEC-11 |
Glyburide | McKesson Contract Packaging | 10-JAN-12 |
Glyburide | Preferred Pharmaceuticals, Inc | 30-JAN-12 |
Glyburide And Metformin Hydrochloride | CorePharma, LLC | 09-FEB-12 |
Glyburide | Physicians Total Care, Inc. | 04-MAR-12 |
Diabeta | Sanofi-Aventis U.S. LLC | 14-MAR-12 |
Glucovance | Physicians Total Care, Inc. | 23-APR-12 |
Glyburide And Metformin Hydrochloride | Greenstone LLC | 16-JUL-12 |
Glyburide And Metformin Hydrochloride | Aphena Pharma Solutions - Tennessee, Inc. | 19-JUL-12 |
Glyburide And Metformin | Teva Pharmaceuticals USA Inc | 23-JUL-12 |
Glyburide | CorePharma, LLC | 22-AUG-12 |
Glyburide | Rebel Distributors Corp | 28-AUG-12 |
Glyburide | Teva Pharmaceuticals USA Inc | 07-SEP-12 |
Glyburide | PD-Rx Pharmaceuticals, Inc. | 07-SEP-12 |
Glyburide | Aurobindo Pharma Limited | 16-OCT-12 |
Glyburide-metformin Hydrochloride | Heritage Pharmaceuticals Inc. | 22-OCT-12 |
Glyburide | Teva Pharmaceuticals USA Inc | 07-DEC-12 |
Glyburide | Greenstone LLC | 07-JAN-13 |
Glyburide And Metformin Hydrochloride | Preferred Pharmaceuticals, Inc. | 14-JAN-13 |
Glyburide And Metformin | Bryant Ranch Prepack | 17-JAN-13 |
Glyburide And Metformin | Bryant Ranch Prepack | 17-JAN-13 |
Glyburide | Bryant Ranch Prepack | 17-JAN-13 |
Glyburide And Metformin | Bryant Ranch Prepack | 18-JAN-13 |
Glyburide | Bryant Ranch Prepack | 21-JAN-13 |
Glyburide | NCS HealthCare of KY, Inc dba Vangard Labs | 28-FEB-13 |
Glyburide | NCS HealthCare of KY, Inc dba Vangard Labs | 04-MAR-13 |
Glyburide | Heritage Pharmaceuticals Inc. | 08-MAR-13 |
Glyburide | Teva Pharmaceuticals USA Inc | 11-MAR-13 |
Glyburide | Cardinal Health | 14-MAR-13 |
Glucovance | Bristol-Myers Squibb Company | 01-APR-13 |
Glyburide | Cardinal Health | 11-APR-13 |
What Glyburide safety concerns are being reported by doctors and researchers in the medical literature?
This report contains aggregated drug side effects and adverse events for Glyburide. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.
DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.
DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.
Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.
Share your experience with Glyburide.